 | |
Subscribe to our Email List
| |
| |
20 Jan 2010
Notice of Interest |
Further to the announcement on the 7 January 2010, the Company received a notification on 19 January 2010 from Henderson Global Investors Ltd that its total interests in the Company, including Contract for Differences ("CfD"), is now 8.14%, due to the new ordinary shares of 0.1 pence ("Ordinary Shares") issued pursuant to the fundraising announced on 8 December 2009.
Henderson Global Investors Ltd's holdings in the Company remain unchanged at 17,636,883 Ordinary Shares and 1,800,000 CfD's.
For further information:
Verona Pharma Plc
Professor Clive Page, Chairman
Tel: 07971 504 931
Evolution Securities Limited (Nominated Adviser)
Barry Saint / Tim Redfern / Esther Lee
Tel: 020 7071 4300
Bishopsgate Communications Ltd.
Robyn Samuelson / Gemma O'Hara
Tel: 0207 562 3350 |
|
| |
| | You can view the Next News Releases item: Fri Mar 26, 2010, Preliminary Unaudited Results for year ended 31 December 2009
You can view the Previous News Releases item: Thu Jan 14, 2010, New Year Progress Report on Verona Pharma plc
You can return to the main News Releases page, or press the Back button on your browser.
|
| | |
